
Upcoming FDA-AACR Workshop Will Discuss Dosage Optimization for Cancer Therapies
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...
AACR will host the inaugural Blood Cancer Discovery Symposium March 4-6, 2024, featuring experts from all areas of blood...
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful...
Charles Swanton, MD, PhD, FAACR, spoke on the role chromosomal instability plays in breast cancer evolution.
“What will you do Monday morning?” was the question posed by the final session on the final full day...
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and...
Studies featured at this year’s San Antonio Breast Cancer Symposium (SABCS) suggest that—in some situations—adjuvant radiotherapy may not be...
A breast cancer diagnosis can pose innumerable challenges, and with the average age at diagnosis dropping, the impact of...
Each December, an impressive cohort of breast cancer researchers gathers for the San Antonio Breast Cancer Symposium (SABCS), one...
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...